Rabeprazole sodium
Rabeprazole Sodium is a prescription proton pump inhibitor that reduces stomach acid production. It's available as 20 mg delayed-release oral tablets, used to treat conditions like acid reflux, ulcers, and heartburn. Manufactured by Torrent Pharmaceuticals Limited and distributed by Proficient Rx LP, it's packaged in bottles of 30, 60, or 90 tablets. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Rabeprazole Sodium is a prescription proton pump inhibitor that reduces stomach acid production. It's available as 20 mg delayed-release oral tablets, used to treat conditions like acid reflux, ulcers, and heartburn. Manufactured by Torrent Pharmaceuticals Limited and distributed by Proficient Rx LP, it's packaged in bottles of 30, 60, or 90 tablets. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Rabeprazole sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Rabeprazole sodium — ANDA 020973 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020973"
}
]
|
| identifier | ANDA020973 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"fda",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Rabeprazole sodium |
